- Total Pro Portfolios with MOGN:
- ProFunds Pharmaceuticals UltraSector Inv PHPIX
- Janus Aspen Global Life Sciences Inst JGLIX
- Kingdon Capital
- ProFunds Pharmaceuticals UltraSector - PHPSX
- show more
- 8
- Fidelity Select Pharmaceuticals FPHAX
- Avenir Corp
- Deerfield Management
- T. Rowe Price Health Sciences Fund - PRHSX
- Total Do-It-Yourself Portfolios with MOGN:
- Gerald Knodel Portfolio 1
- Bunny3 Portfolio 1
- mwarner Portfolio 1
- obak
- chrismer1225 Portfolio 1
- JohnHoey Portfolio 1
- Silver Colston's SEP
- dmavani Portfolio 1
- Steve Norris Portfolio 1
- Me JOESE
- Wizzwatch Market Index
- show more
- 22
- mack karnes Portfolio 1
- ravivk Portfolio 1
- joannco Portfolio 1
- mikerohricht Portfolio 1
- Squeege Purveyors Asset Managment
- Brookside Capital Partners
- vn1066 Portfolio 1
- SUPRATRADE "BUY IT IMMEDIATELY NOW"-0410071423
- alexjent Portfolio 1
- BENITRANS IJ
- New Positions of the Top Traders
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:12 23 07 |
|
Icahn |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
FBR said it is downgrading MGI Pharma (MOGN) to a Market Perform rating following yesterday's rally in the stock. |
|
Not yet rated
Rate now:
|
|
By:bigkid |
Date:11 06 07 |
It's my pharmaceutical play. I have a friend who recommended them. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
MGI Pharma (MOGN) was upgraded from Neutral to Overweight, JP Morgan said. Stock is up 67% on the year, but sales growth and operating leverage potential over the next couple of years is far ahead of its peers. |
|
Not yet rated
Rate now:
|
|
By:supratrade |
Date:10 04 07 |
BUY |
|
Not yet rated
Rate now:
|
|
By:nickish |
Date:08 03 07 |
MEDICAL APPLIANCES |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by Am Tech/JSA Research from Sell to Neutral |
|
Not yet rated
Rate now:
|
|
Date:07 03 07 |
|
it saved my life |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Matrix Research from Hold to Strong Sell |
|
Not yet rated
Rate now:
|
|



